Canada markets closed

Context Therapeutics Inc. (6K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.3000+0.1800 (+16.07%)
At close: 04:51PM CET
Full screen
Loading interactive chart...
  • Simply Wall St.

    Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Context Therapeutics...

  • GlobeNewswire

    Context Therapeutics Reports Full Year 2023 Operating and Financial Results

    CTIM-76 IND filing on track for late March 2024 Cash and cash equivalents of $14.4 million as of December 31, 2023 Company expects its cash and cash equivalents will continue to fund operations into late 2024 PHILADELPHIA, March 21, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the year ended December 31, 2023, and reported on recent and up

  • GlobeNewswire

    Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

    CTIM-76 IND filing on track for late Q1 2024 Cash and cash equivalents of $21.7 million as of September 30, 2023 Company expects its cash and cash equivalents will continue to fund operations into late 2024 PHILADELPHIA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the third quarter ended September 30, 2023, and reported on recent